Drug Trial Radar · NCT00644059
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines
Last checked: Nov 20, 2026Latest source record: Sep 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,902
Actual
Start
Nov 2007
Primary completion
Apr 2010
Study completion Aug 2010
Sponsor
- Lead sponsor
- NovartisNovartis (NVS)
- Sponsor type
- Industry
- Collaborators
- Novartis Vaccines
- First posted
- Mar 26, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 6 months, up to 71 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety and immunogenicity of one or two 0.25 mL or 0.5 mL intramuscular injections of an adjuvanted influenza vaccine compared with non-influenza and non-adjuvanted influenza control vaccines in subjects 6 to \<72 months of age.
Conditions
- Influenza, Human
Interventions
Adjuvanted trivalent inactivated subunit influenza vaccineBiological
Either two intramuscular (IM) injections of half dose or one IM injection of full dose, depending on age of subject, were administered in the deltoid muscle preferably of the non-dominant arm.
Non-adjuvanted trivalent inactivated subunit influenza vaccine or non-adjuvanted trivalent inactivated split influenza vaccineBiological
For both vaccines, either two intramuscular (IM) injections of half dose or one IM injection of full dose, depending on age of subject, were administered in the deltoid muscle preferably of the non-dominant arm.
Meningococcal C conjugate vaccine or tick-borne encephalitis vaccineBiological
1. Meningococcal vaccine: two IM injections 2. Tick-borne encephalitis vaccine: two IM injections
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects (Unprimed) 6 to <36 Months Age With Local and Systemic Reactions After Any Vaccination for All Seasons, Comparison of Adjuvanted Trivalent Influenza Vaccine (aTIV) and Flu Vaccine Control.Time frame: 7 days post-vaccination
- Percentage of Subjects (Unprimed) Aged 6 to <36 Months With Virus-Confirmed Influenza, Comparison of aTIV and Non-flu Vaccine Control (Men C/TBE Vaccine)Time frame: 3 weeks after 2nd vaccination
Locations
101 sites in 3 countries. Site status is shown where the registry gives one.
East Vantaa Clinic
East Vaanta, Finland
Espoo Vaccine Research Clinic
Espoo, Finland
Helsinki South Vaccine Research Clinic
Helsinki, Finland
Helsinki East Vaccine Research Clinic
Helsinki, Finland
Jarvenpaa Vaccine Research Clinic
Jarvenpaa, Finland
Kokkola Vaccine Research Clinic
Kokkola, Finland
Kotka Clinic
Kotka, Finland
Kuopio Vaccine Clinic
Kuopio, Finland
Kuopio Vaccine Research Clinic
Kuopio, Finland
Lahti vaccine research Clinic
Lahti, Finland
Oulu Vaccine Research Clini
Oulu, Finland
Pori Vaccine Research Clinic
Pori, Finland
Seinajoki Clinic
Seinäjoki, Finland
Tampere Vaccine Research Clinic
Tampere, Finland
Turku Clinic
Turku, Finland
Vantaa West Vaccine Research Clinic
Vantaa, Finland
West Vantaa Clinic
West Vantaa, Finland
Praxis Dr med Thilo Heising
Aalen Wasseralfingen, Germany
Praxis Dr med Ursula Hornlein
Berlin, Germany
Praxis Dr med Thomas Richter
Berlin, Germany
Praxis Dipl med Andreas Muhmer
Berlin, Germany
Praxis Dr med Mechthild Vocks-Hauck
Berlin, Germany
Praxis Dr med Klaus-Peter Falkowski
Berlin, Germany
Praxis Dr med Eva Brand
Berlin, Germany
Praxis Dr med Dorothea Budde
Berlin, Germany
Praxis Dr. med. Cornelia Busse
Berlin, Germany
Praxis Dipl. med. F. Temmler / Dipl. med. D. Wenzel
Berlin, Germany
Praxis Dr med Petra van Stiphout
Berlin, Germany
Praxis Dr Luise Schroeter
Berlin, Germany
"Praxis Dr med Dietrich Lasius"
Berlin, Germany
Praxis Dr. med. Petra Sandow
Berlin, Germany
Praxis Dr Norbert Meister
Bindlach, Germany
Praxis Dr med Thomas Tuschen
Binngen Rhein, Germany
Praxis Dr. Elmar Dietmair
Bobingen, Germany
Praxis Dr med Brigitta Becker
Bochum, Germany
Praxis Karl-Heinz Blattel
Braunfels, Germany
Praxis Dr. med. Roland Knecht
Bretten, Germany
Praxis Dr. med. Maria R. Holtorf
Brunsbüttel, Germany
Praxis Dr Klaus Helm
Detmold, Germany
Praxis Joseph Zakarian
Düsseldorf, Germany
Showing 40 of 101 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.